Literature DB >> 22533655

Effect of the rs168924 single-nucleotide polymorphism in the SLC6A2 catecholamine transporter gene on blood pressure in Caucasians.

Oliver Zolk1, Christian Ott, Martin F Fromm, Roland E Schmieder.   

Abstract

The NG_016969.1:g.5003A>G promoter polymorphism (rs168924) in the SLC6A2 norepinephrine transporter gene was found to be predictive of the hypertensive status in a Japanese population, but no data are available for Caucasians. Genotyping for rs168924 was performed in 282 young men with normal blood pressure (BP), grade 1 or 2 hypertension. In addition to casual BP, 24-hour ABPM and echocardiography were performed. Multiple regression analysis revealed a significant association of rs168924 genotype with diagnosis of hypertension (P=.044), casual systolic BP (SBP) levels (P=.028), and daytime ambulatory SBP (P=.02). The finding that rs168924 was also significantly associated with diastolic posterior wall thickness (P=.041), an echocardiographic index of hypertensive cardiac target organ damage, further supports the notion that the rs168924 SNP in SLC6A2 in fact might influence BP. Unlike previous findings in a Japanese population, in our Caucasian study cohort the presence of the minor rs168924 G allele was associated with lower prevalence of hypertension.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22533655      PMCID: PMC8108780          DOI: 10.1111/j.1751-7176.2012.00618.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  20 in total

1.  Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance.

Authors:  Christoph Schroeder; Jens Tank; Michael Boschmann; Andre Diedrich; Arya M Sharma; Italo Biaggioni; Friedrich C Luft; Jens Jordan
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

Review 2.  Sympathetic nerve biology in essential hypertension.

Authors:  M Esler; M Rumantir; D Kaye; G Jennings; J Hastings; F Socratous; G Lambert
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-12       Impact factor: 2.557

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.

Authors:  Chun-Hyung Kim; Maureen K Hahn; Yoosook Joung; Susan L Anderson; Angela H Steele; Michelle S Mazei-Robinson; Ian Gizer; Martin H Teicher; Bruce M Cohen; David Robertson; Irwin D Waldman; Randy D Blakely; Kwang-Soo Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-04       Impact factor: 11.205

5.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

6.  Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans.

Authors:  Utkarsh Kohli; Maureen K Hahn; Brett A English; Gbenga G Sofowora; Mordechai Muszkat; Chun Li; Randy D Blakely; C Michael Stein; Daniel Kurnik
Journal:  Pharmacogenet Genomics       Date:  2011-04       Impact factor: 2.089

7.  MDR1 genotype-dependent regulation of the aldosterone system in humans.

Authors:  Oliver Zolk; Johannes Jacobi; Andreas Pahl; Martin F Fromm; Roland E Schmieder
Journal:  Pharmacogenet Genomics       Date:  2007-02       Impact factor: 2.089

8.  Multiple genes for essential-hypertension susceptibility on chromosome 1q.

Authors:  Yen-Pei Christy Chang; Xin Liu; James Dae Ok Kim; Morna A Ikeda; Marnie R Layton; Alan B Weder; Richard S Cooper; Sharon L R Kardia; D C Rao; Steve C Hunt; Amy Luke; Eric Boerwinkle; Aravinda Chakravarti
Journal:  Am J Hum Genet       Date:  2006-12-20       Impact factor: 11.025

9.  Left-ventricular structure and function are influenced by angiotensinogen gene polymorphism (-20 A/C) in young male patients.

Authors:  Christian Ott; Thomas Schwarz; Karl F Hilgers; Reinhold Kreutz; Markus P Schlaich; Roland E Schmieder
Journal:  Am J Hypertens       Date:  2007-09       Impact factor: 2.689

10.  Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension.

Authors:  R E Schmieder; M R Langenfeld; A Friedrich; H P Schobel; C D Gatzka; H Weihprecht
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

View more
  1 in total

1.  No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA.

Authors:  Patrick Vizeli; Henriette E Meyer Zu Schwabedissen; Matthias E Liechti
Journal:  Eur J Clin Pharmacol       Date:  2017-12-02       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.